logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Salamanca University Hospital

+34923291100
Source: Site record.
https://www.saludcastillayleon.es/ciudadanos/es/mapa-centros-salud-castilla-leon/141809

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Salamanca University Hospital is the premier medical facility in the Castilla y León region and ranks among the top hospitals in Spain. Functioning as a central teaching hub affiliated with the historic University of Salamanca, this public hospital complex features a modern infrastructure spanning over 177,000 square metres. Highly regarded for its clinical excellence, it is equipped with the region's highest concentration of high-tech medical machinery, including a specialized 3-Tesla Magnetic Resonance imaging platform. The hospital operates as a vital center for specialized healthcare, renowned for its cutting-edge oncology and transplant programs, alongside groundbreaking biomedical research conducted through the Institute of Biomedical Research of Salamanca

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Trial-derived.
209Total Trials
Source: Trial-derived.
42Recruiting Trials
Source: Trial-derived.
102Active Trials
Source: Trial-derived.
77Completed Trials
Source: Trial-derived.
239Unique Conditions
Source: Trial-derived.
161Unique Sponsors

Conditions

Source: Trial-derived. Multiple Myeloma (13)Source: Trial-derived. Acute Myeloid Leukemia (8)Source: Trial-derived. Myelodysplastic Syndromes (8)Source: Trial-derived. Atrial Fibrillation (6)Source: Trial-derived. Relapsed/Refractory Follicular Lymphoma (5)Source: Trial-derived. Stroke (5)Source: Trial-derived. Chronic Lymphocytic Leukemia (4)Source: Trial-derived. Coronary Artery Disease (4)

Sponsors

Source: Trial-derived. Celgene (14)Source: Trial-derived. Fundación GECP (8)Source: Trial-derived. Hoffmann-La Roche (8)Source: Trial-derived. Takeda (8)Source: Trial-derived. Millennium Pharmaceuticals, Inc. (7)Source: Trial-derived. PETHEMA Foundation (7)Source: Trial-derived. Regeneron Pharmaceuticals (7)Source: Trial-derived. AbbVie (6)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Echocardiography
Source: AI-inferred. PET-CT
Source: AI-inferred. CT Scan
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. MRI

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Percutaneous left atrial appendage closure
Source: AI-inferred. Blood transfusion service
Source: AI-inferred. Apheresis
Source: AI-inferred. Lumbar puncture

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Minimal residual disease testing
Source: AI-inferred. Autologous haematopoietic stem cell transplantation
Source: AI-inferred. AAV-specific T-cell immune response assay
Source: AI-inferred. Allogeneic haematopoietic cell transplantation programme
Source: AI-inferred. Allogeneic haematopoietic stem cell transplantation programme
Source: AI-inferred. Anti-AAV neutralizing antibody assay
Source: AI-inferred. CAR T-cell product receipt, handling and infusion
Source: AI-inferred. CAR T-cell quantification